Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective
Kidney and Blood Pressure Research · 2025
DOI: 10.1159/000545638 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Kidney and Blood Pressure Research, 2025. Verfasst von Matteo Floris und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Dialysis, and Transplantation, ARNAS G. Brotzu, Cagliari, Italy. Hauptthemen laut MEDLINE: Stomach Neoplasms, Antineoplastic Combined Chemotherapy Protocols, Esophageal Neoplasms, Acute Kidney Injury. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
The FLOT regimen, a combination of fluorouracil, leucovorin, oxaliplatin, and docetaxel, is a standard treatment for gastric and esophagogastric junction cancers, but concerns exist about its potential renal toxicity. The exact prevalence and severity of renal toxicity need to be well documented, and this knowledge gap could impact the optimal use of the FLOT regimen in clinical practice. We aimed to evaluate the renal toxicity profile of the FLOT regimen with a specific focus on acute kidney disease (AKD) onset in a real-life setting and explore associated risk factors.
Methods
We conducted a multicenter retrospective study involving 96 patients treated with preoperatory FLOT. The incidence of AKD and potential risk factors were identified.
Results
AKD occurred in 3 patients (incidence rate of 0.0122 cases/month of follow-up). Oral antidiabetic agents and prostate hypertrophy emerged as significant predictors of AKD.
Conclusion
AKD is uncommon in patients treated with the preoperatory FLOT regimen. Our findings highlight the importance of diligent renal function monitoring and appropriate preventive strategies in patients undergoing FLOT treatment. These results encourage the conduction of further studies and clinical experience in larger populations and patients with lower baseline estimated glomerular filtration rate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Dialysis, and Transplantation, ARNAS G. Brotzu, Cagliari, Italy.
- Department of Medical Oncology Ospedale San Raffaele, Vita-Salute University San Raffaele, Comprehensive Cancer Center, Milan, Italy.
- Medical Oncology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
- Biorek srl, San Raffaele Scientific Institute, Milan, Italy.
- Medical Oncology Unit, University Hospital and University of Cagliari, Cagliari, Italy.
- Department of Medical Science and Public Health, University of Cagliari, Cagliari, Italy.
Zitieren
APA
Floris, M., Angioi, A., Liscia, N., Ghidini, M., Cinque, A., Puzzoni, M., Pani, A., Lepori, N., Scartozzi, M., Dettori, M., Cabiddu, G., Testoni, P., Cascinu, S., Mazza, E., & Trevisani, F. (2025). Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective. Kidney and Blood Pressure Research. https://doi.org/10.1159/000545638
Vancouver
Floris M, Angioi A, Liscia N, Ghidini M, Cinque A, Puzzoni M, et al. Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective. Kidney and Blood Pressure Research. 2025. doi:10.1159/000545638
BibTeX
@article{Floris2025,
author = {Floris, Matteo and Angioi, Andrea and Liscia, Nicole and Ghidini, Michele and Cinque, Alessandra and Puzzoni, Marco and Pani, Antonello and Lepori, Nicola and Scartozzi, Mario and Dettori, Manuela and Cabiddu, Gianfranca and Testoni, Paola and Cascinu, Stefano and Mazza, Elena and Trevisani, Francesco},
title = {Preoperatory FLOT Regimen for Gastroesophageal Cancer and Renal Function: A New Onco-Nephrological Perspective},
journal = {Kidney and Blood Pressure Research},
year = {2025},
doi = {10.1159/000545638}
}
EUVIMED